The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksARIX.L Share News (ARIX)

  • There is currently no data for ARIX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

DIRECTOR DEALINGS: Ferro-Alloy Resources CEO lifts stake to 13%

Fri, 05th May 2023 13:35

(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced this week and not separately reported by Alliance News:

----------

Ferro-Alloy Resources Ltd - vanadium producer in southern Kazakhstan - Chief Executive Officer Nicholas Bridgen buys 6.4 million shares at 10.15p, worth GBP649,600, on Tuesday. Now has 59.5 million shares, a 13% stake.

----------

Coca-Cola Europacific Partners PLC - Uxbridge, west London-based soft drinks bottler - Chief Commercial Officer Stephen Lusk sells 7,000 shares at USD66.00, worth USD461,970, on Wednesday in New York.

----------

Glenveagh Properties PLC - Dublin-based housebuilder - CEO Stephen Garvey buys 292,239 shares at EUR0.94 and EUR0.95, worth EUR277,055, on Tuesday and Thursday in Dublin.

----------

Arix Bioscience PLC - London-based investor in biotechnology companies - Chair Peregrine Moncreiffe buys 160,000 shares at 102.5p and 104.8p, worth GBP165,963 in total, on Thursday and Friday last week.

----------

Smith & Nephew PLC - London-based medical equipment maker - Chief Corporate Development & Corporate Affairs Officer Phil Cowdy sells 12,083 shares at GBP12.83, worth GBP155,059, on Thursday last week. Bradley Cannon, president of Global Orthopaedics, sells 9,500 shares at GBP12.93, worth GBP122,805, on Tuesday this week. Cowdy still has 49,001 shares, and Cannon has 117,819.

----------

ProCook Group PLC - Gloucester-based kitchenware retailer - CEO Daniel O'Neill buys 510,000 shares at GBP0.27, worth GBP137,700, on Thursday.

----------

Morgan Advanced Materials PLC - Windsor, England-based specialist industrial product manufacturer - Chair-Designate Ian Marchant buys 35,000 shares at GBP3.13, worth GBP109,550, on Tuesday.

----------

RWS Holdings PLC - Buckinghamshire, England-based technology-enabled language services provider - CEO Ian El-Mokadem buys 40,000 shares at 253.8p, worth GBP101,520, on Tuesday. Now has 190,000 shares.

----------

Hostmore PLC - West Sussex, England-based owner of casual dining brand Fridays - Senior Independent Director David Lis and associate Patricia Lis buy 456,608 shares at GBP0.17 and GBP0.15, worth GBP75,093, on Tuesday. David Lis now interested in 871,608 shares. Hostmore on Tuesday confirms Interim CEO Julie McEwan as permanent CEO. It also announces a new cost-reduction programme aimed at achieving GBP4.1 million in annualised savings. This is additional to the GBP1.8 million of annualised savings achieved in 2022.

----------

Aterian PLC - metal exploration and development in Morocco and Rwanda - Director Charles Bray buys 7.5 million shares at 0.80p and 0.82p, worth GBP60,625 in total, on Tuesday and Wednesday.

----------

Gym Group PLC - Croydon, England-based chain operator of 230 low-cost gyms - Non-Executive Director Richard Stables buys 50,000 shares at 107.0p, worth GBP53,500, on Wednesday. Four other directors buys 70,000 shares in total on the same day.

----------

Jadestone Energy PLC - oil and gas exploration and production in Australia, Malaysia, Indonesia, Thailand and Vietnam - Non-Executive David Neuhauser buys 100,000 shares via Livermore Partners LLC at GBP0.50, worth GBP50,000, on Wednesday. Livermore now holds 31.5 million shares, a 7.1% stake.

----------

By Tom Waite, Alliance News editor

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
8 Oct 2021 21:39

IN BRIEF: Arix Bioscience investee Pyxis Oncology prices Nasdaq IPO

IN BRIEF: Arix Bioscience investee Pyxis Oncology prices Nasdaq IPO

Read more
7 Oct 2021 16:38

EXECUTIVE CHANGES: Arix confirms CEO; Schroder RE picks new chair

EXECUTIVE CHANGES: Arix confirms CEO; Schroder RE picks new chair

Read more
30 Sep 2021 06:42

CORRECT: Arix investee doses first patient in tumour drug trial

CORRECT: Arix investee doses first patient in tumour drug trial

Read more
29 Sep 2021 06:50

IN BRIEF: Arix doses first patient in tumour-specific drug trial

IN BRIEF: Arix doses first patient in tumour-specific drug trial

Read more
12 Aug 2021 12:12

Arix Bioscience portfolio value falls as stock picks struggle

Arix Bioscience portfolio value falls as stock picks struggle

Read more
5 Aug 2021 16:18

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
6 Jul 2021 14:52

EXECUTIVE CHANGES: TP's interim CEO; National Grid taps Meggitt chief

EXECUTIVE CHANGES: TP's interim CEO; National Grid taps Meggitt chief

Read more
7 Jun 2021 16:05

UK shareholder meetings calendar - next 7 days

UK shareholder meetings calendar - next 7 days

Read more
4 Jun 2021 19:21

IN BRIEF: Arix investee Harpoon presents updated data for HPN424

IN BRIEF: Arix investee Harpoon presents updated data for HPN424

Read more
12 May 2021 16:04

UK shareholder meetings calendar - next 7 days

UK shareholder meetings calendar - next 7 days

Read more
30 Apr 2021 16:16

EXECUTIVE CHANGES: Prudential names board of Jackson Financial

EXECUTIVE CHANGES: Prudential names board of Jackson Financial

Read more
28 Apr 2021 09:32

CORRECT (Apr 27): Arix portfolio firm partners with Daiichi, CANbridge

CORRECT (Apr 27): Arix portfolio firm partners with Daiichi, CANbridge

Read more
27 Apr 2021 15:47

IN BRIEF: Arix partners with Daiichi Sankyo, CANbridge Pharmaceuticals

IN BRIEF: Arix partners with Daiichi Sankyo, CANbridge Pharmaceuticals

Read more
26 Apr 2021 16:02

EXECUTIVE CHANGES: Ebiquity appoints ITV executive Izlan to board

EXECUTIVE CHANGES: Ebiquity appoints ITV executive Izlan to board

Read more
7 Apr 2021 20:00

IN BRIEF: Arix Bioscience investee Artios collaborates with Novartis

IN BRIEF: Arix Bioscience investee Artios collaborates with Novartis

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.